Enterologics, Inc. (ELGO)
-OTC Markets 0.02 May 6, 11:55AM EDT|Pre-Market
:
NaN
| Prev Close: | 0.02 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | -2.073 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.01 - 0.40 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 10,923 |
|---|
| Market Cap: | 557.44K |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.03 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ENTEROLOGICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 20)
- ENTEROLOGICS, INC. FinancialsEDGAR Online Financials(Thu, Apr 4)
- ENTEROLOGICS, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Fri, Mar 29)
- ENTEROLOGICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Nov 14)
- ENTEROLOGICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Aug 14)
- ENTEROLOGICS, INC. FinancialsEDGAR Online Financials(Thu, May 24)
- ENTEROLOGICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 15)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Enterologics, Inc., a development stage company, focuses on the development of probiotic bio-therapeutic products. It focuses on developing probiotic bio-therapeutic products for the treatment of gastrointestinal disorders, including pouchitis, ir...
View More 
0.52%